These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1924636)

  • 1. Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.
    Axelsson R; Nilsson A; Christensson E; Björk A
    Psychopharmacology (Berl); 1991; 104(3):287-92. PubMed ID: 1924636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    Findling RL; Robb A; Nyilas M; Forbes RA; Jin N; Ivanova S; Marcus R; McQuade RD; Iwamoto T; Carson WH
    Am J Psychiatry; 2008 Nov; 165(11):1432-41. PubMed ID: 18765484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats.
    McMillen BA; Walter S; Williams HL; Myers RD
    Alcohol; 1994; 11(3):203-6. PubMed ID: 8060520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats.
    Myers RD; Lankford M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):91-5. PubMed ID: 9443541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
    McEvoy JP; Daniel DG; Carson WH; McQuade RD; Marcus RN
    J Psychiatr Res; 2007 Dec; 41(11):895-905. PubMed ID: 17631314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of amperozide, a new antipsychotic drug, on plasma corticosterone concentration in the rat.
    Albinsson A; Andersson G
    Life Sci; 1992; 51(19):1535-44. PubMed ID: 1359366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and tolerability of raclopride, a specific D2 receptor blocker, in acute schizophrenia: an open trial.
    Cookson JC; Natorf B; Hunt N; Silverstone T; Uppfeldt G
    Int Clin Psychopharmacol; 1989 Jan; 4(1):61-70. PubMed ID: 2531773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.
    Wiesel FA; Nordström AL; Farde L; Eriksson B
    Psychopharmacology (Berl); 1994 Feb; 114(1):31-8. PubMed ID: 7846205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.